Clinical Trial Update: Enterprise 2 Vascular Reconstruction Device

View source ↗

Summary

The clinical trial update indicates that enrollment for the Enterprise 2 Vascular Reconstruction Device is ongoing by invitation for patients with aneurysm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysm

Snippet

Sponsor: Methodist Health System | Conditions: Aneurysm | Status: ENROLLING_BY_INVITATION